Pathways Laid Down By The CMS For Drug Price Negotiations
The Centers for Medicare & Medicaid Services issued preliminary instructions on March 15 on how it intends to negotiate medication pricing under Medicare, a...
MHRA In The UK To Assess Stem Cell Robots For Cell Therapies
The Medicines and Healthcare Products Regulatory Agency's (MHRA) UK stem cell bank is trailing a new and innovative robot that would grow stem cells.
The...
Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study
The combination of modulator therapies tezacaftor (TEZ) and ivacaftor (IVA) for cystic fibrosis (CF) has shown long-term safety as well as clinical benefit in...
SVB Collapse And Its Implications On Biotechnology Sector
Within just 48 hours, the bank that several new biotechnology companies had relied on for ages was gone.
On March 10, the Federal Deposit Insurance...
Cell And Gene Therapy Boost With Novel UK Biotech Centres
The National Health Service Blood and Transplant from the UK, which takes care of blood as well as platelet donations as well as organ,...
US President Looks To Double The Drugs For Price Negotiation
President Joe Biden is looking to double the number of medicines that Medicare can help negotiate rates for and thereby enable the government to...
Monash University In Australia Leads $15M Mitochondrial Clinical Trial Drive
Almost 50 children in Australia are born every year with a devastating mitochondrial disease that has an expected lifespan of just 5 years. In...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...